Association of heart rate with heart failure outcomes and the effects of empagliflozin in patients with preserved ejection fraction - EMPEROR-Preserved trial

被引：0
|
作者：
Boehm, M. [1 ]
Anker, S. D. [2 ]
Mahfoud, F. [1 ]
Filippatos, G. [3 ]
Ferreira, J. P. [4 ]
Pocock, S. J. [5 ]
Brueckmann, M. [6 ]
Linetzky, B. [7 ]
Schueler, E. [8 ]
Wanner, C. [9 ]
Zannad, F. [4 ]
Packer, M. [10 ]
Butler, J. [11 ]
机构：
[1] Univ Hosp Saarland, Clin Internal Med Cardiol Angiol & Intens Care Me, Homburg, Germany
[2] Charite Univ Med Berlin, Dept Cardiol CVK, Berlin, Germany
[3] Natl & Kapodistrian Univ Athens, Athens Univ Hosp, Sch Med, Athens, Greece
[4] Univ Lorraine, Nancy, France
[5] London Sch Hyg & Trop Med, London, England
[6] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[7] Eli Lilly Interamer Inc, Buenos Aires, DF, Argentina
[8] mainanalyt GmbH, Sulzbach, Germany
[9] Wuerzburg Univ Clin, Wurzburg, Germany
[10] Baylor Univ Med Ctr, Dallas, TX USA
[11] Baylor Scott & White Hlth, Dallas, TX USA
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：983 / 983
页数：1
相关论文
共 50 条
  • [41] Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction
    Lam, Phillip H.
    Dooley, Daniel J.
    Deedwania, Prakash
    Singh, Steven N.
    Bhatt, Deepak L.
    Morgan, Charity J.
    Butler, Javed
    Mohammed, Selma F.
    Wu, Wen-Chih
    Panjrath, Gurusher
    Zile, Michael R.
    White, Michel
    Arundel, Cherinne
    Love, Thomas E.
    Blackman, Marc R.
    Allman, Richard M.
    Aronow, Wilbert S.
    Anker, Stefan D.
    Fonarow, Gregg C.
    Ahmed, Ali
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (15) : 1861 - 1871
  • [42] Design of the EMPERIAL-preserved trial of empagliflozin in patients with chronic heart failure with preserved ejection fraction
    Ponikowski, P.
    Abraham, W. T.
    Lindenfeld, J.
    Zeller, C.
    Macesic, H.
    Brueckmann, M.
    Salsali, A.
    Anker, S. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 48 - 49
  • [43] Empagliflozin in the treatment of heart failure with preserved ejection fraction
    Morbach, C.
    Frantz, S.
    Nitschmann, S.
    INNERE MEDIZIN, 2022, 63 (07): : 808 - 809
  • [44] Malnutrition in real-world patients hospitalized for heart failure with preserved ejection fraction and its potential impact on generalizability of EMPEROR-Preserved trial
    Takeuchi, Shinsuke
    Kohno, Takashi
    Goda, Ayumi
    Shiraishi, Yasuyuki
    Saji, Mike
    Nagatomo, Yuji
    Tanaka, Toshikazu D.
    Takei, Makoto
    Nakano, Shintaro
    Soejima, Kyoko
    Kohsaka, Shun
    Yoshikawa, Tsutomu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 370 : 263 - 270
  • [45] Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age
    Boehm, Michael
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Abdin, Amr
    Mahfoud, Felix
    Brueckmann, Martina
    Gollop, Nicholas D.
    Iwata, Tomoko
    Ponikowski, Piotr
    Wanner, Christoph
    Zannad, Faiez
    Packer, Milton
    Anker, Stefan D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (01) : 1 - 18
  • [46] Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
    Poppe, Katrina K.
    Doughty, Robert N.
    HEART FAILURE CLINICS, 2014, 10 (03) : 503 - +
  • [47] Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction
    Butler, Javed
    Filippatos, Gerasimos
    Siddiqi, Tariq Jamal
    Ferreira, Joao Pedro
    Brueckmann, Martina
    Bocchi, Edimar
    Bohm, Michael
    Chopra, Vijay K.
    Giannetti, Nadia
    Iwata, Tomoko
    Januzzi, James L.
    Kaul, Sanjay
    Pina, Ileana L.
    Ponikowski, Piotr
    Rauch-Krohnert, Ursula
    Shah, Sanjiv J.
    Senni, Michele
    Sumin, Mikhail
    Verma, Subodh
    Zhang, Jian
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    Anker, Stefan D.
    CIRCULATION, 2022, 146 (14) : 1046 - 1055
  • [48] Research in brief: Empagliflozin for patients with heart failure and preserved ejection fraction
    Pooni, Rajan S.
    Ismail, Tevfik F.
    CLINICAL MEDICINE, 2022, 22 (01) : 75 - 76
  • [49] Heart Rate in Preserved Ejection Fraction Heart Failure
    Bristow, Michael R.
    Altman, Natasha L.
    JACC-HEART FAILURE, 2017, 5 (11) : 792 - 794
  • [50] Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction
    O'Neal, Wesley T.
    Sandesara, Pratik B.
    Samman-Tahhan, Ayman
    Kelli, Heval M.
    Hammadah, Muhammad
    Soliman, Elsayed Z.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (11) : 1212 - 1219
12345